View More Recent Stories
-
H.C. Wainwright Reiterates Buy Rating on BioNTech (BNTX)
-
BMO Capital: 'BNT324 Granted Fast Track Designation, An Incremental Positive' for BioNTech (BNTX)
-
BioNTech SE (BNTX): FDA has placed partial clinical hold on multicenter, open-label, first-in-human Phase 1 clinical (NCT05653752) trial sponsored by MediLink
